| # | Title | Journal | Year | Citations |
|---|
| 1 | Is There Still a Glass Ceiling for Women in Academic Surgery? | Annals of Surgery | 2011 | 404 |
| 2 | PKM2 methylation by CARM1 activates aerobic glycolysis to promote tumorigenesis | Nature Cell Biology | 2017 | 212 |
| 3 | Why the stroma matters in breast cancer | Cell Adhesion and Migration | 2012 | 196 |
| 4 | Cis-element mutated in GATA2-dependent immunodeficiency governs hematopoiesis and vascular integrity | Journal of Clinical Investigation | 2012 | 162 |
| 5 | Preconception Mental Health Predicts Pregnancy Complications and Adverse Birth Outcomes: A National Population-Based Study | Maternal and Child Health Journal | 2012 | 78 |
| 6 | Discovering Transcription Factor Binding Sites in Highly Repetitive Regions of Genomes with Multi-Read Analysis of ChIP-Seq Data | PLoS Computational Biology | 2011 | 73 |
| 7 | Identification of a novel class of RIP1/RIP3 dual inhibitors that impede cell death and inflammation in mouse abdominal aortic aneurysm models | Cell Death and Disease | 2019 | 69 |
| 8 | PP2A-B′ holoenzyme substrate recognition, regulation and role in cytokinesis | Cell Discovery | 2017 | 68 |
| 9 | Expert conference on cancer pain assessment and classification--the need for international consensus: working proposals on international standards | BMJ Supportive and Palliative Care | 2011 | 56 |
| 10 | Central nervous system involvement in diffuse large B-cell lymphoma: an analysis of risks and prevention strategies in the post-rituximab era | Leukemia and Lymphoma | 2014 | 54 |
| 11 | Hesperetin, a potential therapy for carcinoid cancer | American Journal of Surgery | 2011 | 52 |
| 12 | VcR‐CVAD induction chemotherapy followed by maintenance rituximab in mantle cell lymphoma: a Wisconsin Oncology Network study | British Journal of Haematology | 2011 | 48 |
| 13 | Transcription factor mutations as a cause of familial myeloid neoplasms | Journal of Clinical Investigation | 2019 | 47 |
| 14 | Preliminary Report of a Multicenter Prospective Phase II Study of DA-EPOCH-R in MYC-Rearranged Aggressive B-Cell Lymphoma | Blood | 2014 | 40 |
| 15 | Correlation of Chromosomal Instability, Telomere Length and Telomere Maintenance in Microsatellite Stable Rectal Cancer: A Molecular Subclass of Rectal Cancer | PLoS ONE | 2013 | 37 |
| 16 | Long term efficacy and QOL data of chemohormonal therapy (C-HT) in low and high volume hormone naïve metastatic prostate cancer (PrCa): E3805 CHAARTED trial | Annals of Oncology | 2016 | 35 |
| 17 | Impact of the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial on Clinical Management of the Axilla in Older Breast Cancer Patients: A SEER-Medicare Analysis | Annals of Surgical Oncology | 2013 | 34 |
| 18 | Differential internalization of hu14.18-IL2 immunocytokine by NK and tumor cell: impact on conjugation, cytotoxicity, and targeting | Journal of Leukocyte Biology | 2011 | 32 |
| 19 | Tissue factor-factor VIIa complex triggers protease activated receptor 2-dependent growth factor release and migration in ovarian cancer | Gynecologic Oncology | 2017 | 30 |
| 20 | Capturing relevant extracellular matrices for investigating cell migration | F1000Research | 2015 | 29 |
| 21 | Integrating emerging treatment options in mantle cell lymphoma | Clinical Advances in Hematology and Oncology | 2013 | 29 |
| 22 | In Silico Modeling and Scoring of PROTAC-Mediated Ternary Complex Poses | Journal of Medicinal Chemistry | 2022 | 29 |
| 23 | Thiocoraline activates the Notch pathway in carcinoids and reduces tumor progression in vivo | Cancer Gene Therapy | 2014 | 27 |
| 24 | Transformation of epithelial cells through recruitment leads to polyclonal intestinal tumors | Proceedings of the National Academy of Sciences of the United States of America | 2013 | 25 |
| 25 | Identification of small molecule enzyme inhibitors as broad-spectrum anthelmintics | Scientific Reports | 2019 | 25 |
| 26 | PKM2‐TMEM33 axis regulates lipid homeostasis in cancer cells by controlling SCAP stability | EMBO Journal | 2021 | 24 |
| 27 | Immune system and intestinal microbiota determine efficacy of androgen deprivation therapy against prostate cancer | EMBO Journal | 2022 | 23 |
| 28 | Expression of the Active Notch1 Decreases MTC Tumor Growth In Vivo | Journal of Surgical Research | 2011 | 22 |
| 29 | Immunotherapy for prostate cancer: False promises or true hope? | Cancer | 2016 | 22 |
| 30 | Blood disease–causing and –suppressing transcriptional enhancers: general principles and GATA2 mechanisms | Blood Advances | 2019 | 22 |
| 31 | Decoding an Organ Regeneration Switch by Dissecting Cardiac Regeneration Enhancers | Development (Cambridge) | 2020 | 20 |
| 32 | Small Molecule Inhibitors of Metabolic Enzymes Repurposed as a New Class of Anthelmintics | ACS Infectious Diseases | 2018 | 18 |
| 33 | STAT-ART: The Promise and Practice of a Rapid Palliative Single Session of MR-Guided Online Adaptive Radiotherapy (ART) | Frontiers in Oncology | 2019 | 18 |
| 34 | Patient Demographic and Tumor Characteristics Influencing Oncologist Follow-Up Frequency in Older Breast Cancer Survivors | Annals of Surgical Oncology | 2013 | 17 |
| 35 | Patient Derived Models to Study Head and Neck Cancer Radiation Response | Cancers | 2020 | 16 |
| 36 | Validation of Six Genetic Determinants of Susceptibility to Estrogen-Induced Mammary Cancer in the Rat and Assessment of Their Relevance to Breast Cancer Risk in Humans | G3: Genes, Genomes, Genetics | 2014 | 13 |
| 37 | Bendamustine + rituximab chemoimmunotherapy and maintenance lenalidomide in relapsed, refractory chronic lymphocytic leukaemia and small lymphocytic lymphoma: A Wisconsin Oncology Network Study | British Journal of Haematology | 2016 | 13 |
| 38 | VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study | Clinical Lymphoma, Myeloma and Leukemia | 2018 | 13 |
| 39 | Anti-inflammatory Activity of Curcumin in Gel Carriers on Mice with Atrial Edema | Journal of Oleo Science | 2020 | 12 |
| 40 | Rituximab and CHOP Chemotherapy Plus GM-CSF for Previously Untreated Diffuse Large B-Cell Lymphoma in the Elderly: A Wisconsin Oncology Network Study | Clinical Lymphoma, Myeloma and Leukemia | 2010 | 11 |
| 41 | Determining breast cancer axillary surgery within the surveillance epidemiology and end results‐Medicare database | Journal of Surgical Oncology | 2014 | 11 |
| 42 | Potential cytochrome P-450 drug–drug interactions in adults with metastatic solid tumors and effect on eligibility for Phase I clinical trials | American Journal of Health-System Pharmacy | 2015 | 11 |
| 43 | Biemamides A–E, Inhibitors of the TGF-β Pathway That Block the Epithelial to Mesenchymal Transition | Organic Letters | 2018 | 11 |
| 44 | CX-2009, a CD166-directed probody drug conjugate (PDC): Results from the first-in-human study in patients (Pts) with advanced cancer including breast cancer (BC). | Journal of Clinical Oncology | 2020 | 10 |
| 45 | Establishment of a Cell-Type-Specific Genetic Network by the Mediator Complex Component Med1 | Molecular and Cellular Biology | 2013 | 9 |
| 46 | The Impact of Phosphorylation on Electron Capture Dissociation of Proteins: A Top-Down Perspective | Journal of the American Society for Mass Spectrometry | 2017 | 9 |
| 47 | Current Status of Targeted Therapies for Mantle Cell Lymphoma | Drugs | 2011 | 8 |
| 48 | Compensatory expression of NRF2-dependent antioxidant genes is required to overcome the lethal effects of Kv11.1 activation in breast cancer cells and PDOs | Redox Biology | 2021 | 7 |
| 49 | The natural history of fibroblast growth factor receptor (FGFR)-altered cholangiocarcinoma (CCA). | Journal of Clinical Oncology | 2020 | 7 |
| 50 | Yttrium 90-ibritumomab tiuxetan plus rituximab maintenance as initial therapy for patients with high-tumor-burden follicular lymphoma: a Wisconsin Oncology Network study | Clinical Advances in Hematology and Oncology | 2014 | 7 |
